INTRODUCTION: The Introduction portion of this proposal provides a general overview of the entire proj ect including Aims, Background, Preliminary results, and our Methodological approach. Our overall strategy to achieving the goals of the Alzheimer's Disease Neuroimaging Initiative (ADNI) are described, as well as a specific plan for implementation including governance structure, deliverables and timelines. ADMINISTRATIVE CORE: The Administrative Core, is directed by Dr. Michael Weiner, PI of the entire ADNI application, based at UCSF. This Core will be responsible for overseeing all aspects of the entire ADNI including the monitoring all financial and budetary aspects of the project. INFORMATICS CORE: The Informatics Core (IC), based at the Laboratory ofNeuroimaging (LONI) at UCLA will be directed by Dr. Arthur Toga. The IC will be responsible for receving, archiving, and displaying all MRI and PET data including all raw and processed data. All of this data will be available to ADNI investigators, and to the general public within weeks-months after receipt. The IC also describes a number of informatics and image processing and image display tools which will be used by the ADNI. Finally, the IC describes mechanisms by which clinical and cognitive data, stored at the UCSD ADCS group will be linked to the image data at LONI. This will facilitate queries and analyses which utilize clinical, cognitive, and imaging data. All raw and processed image data, as well as all clinical and biomarker data, will rapidly be made avialable on public websites. BIOSTATISTICS CORE: The Biostatistics Core (BC) will be directed by Dr. Laurel Beckett at UC Davis, and will consist of statisticans at UCSD and UCSF as well. The BC will implement mechanisms for data monitoring as data is acquired, to identify outliers and errrors. In addition, the BC describes a statistical approach to analyze data acquired by the ADNI, in order to test the apriori hypotheses described in the proposal, and presents a power analysis to justify the proposed sample size.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01AG024904-04S1
Application #
7596019
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4 (M6))
Program Officer
Buckholtz, Neil
Project Start
2004-09-30
Project End
2009-08-31
Budget Start
2008-04-15
Budget End
2008-08-31
Support Year
4
Fiscal Year
2008
Total Cost
$2,000,000
Indirect Cost
Name
Northern California Institute Research & Education
Department
Type
DUNS #
613338789
City
San Francisco
State
CA
Country
United States
Zip Code
94121
Mielke, Michelle M; Hagen, Clinton E; Xu, Jing et al. (2018) Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimers Dement 14:989-997
Van Hooren, Roy W E; Riphagen, Joost M; Jacobs, Heidi I L et al. (2018) Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer's disease: a longitudinal cohort study. Alzheimers Res Ther 10:88
Sui, Xiuchao; Rajapakse, Jagath C; Alzheimer's Disease Neuroimaging Initiative (2018) Profiling heterogeneity of Alzheimer's disease using white-matter impairment factors. Neuroimage Clin 20:1222-1232
van Opbroek, Annegreet; Achterberg, Hakim C; Vernooij, Meike W et al. (2018) Transfer learning by feature-space transformation: A method for Hippocampus segmentation across scanners. Neuroimage Clin 20:466-475
Liu, Changan; Chyr, Jacqueline; Zhao, Weiling et al. (2018) Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development. Front Genet 9:410
Ridge, Perry G; Wadsworth, Mark E; Miller, Justin B et al. (2018) Assembly of 809 whole mitochondrial genomes with clinical, imaging, and fluid biomarker phenotyping. Alzheimers Dement 14:514-519
Bos, Isabelle; Vos, Stephanie J B; Jansen, Willemijn J et al. (2018) Amyloid-?, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data. Front Aging Neurosci 10:193
Tucholka, Alan; Grau-Rivera, Oriol; Falcon, Carles et al. (2018) Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-? and Tau. J Alzheimers Dis 61:1575-1587
Zhang, Hua; Therriault, Joseph; Kang, Min Su et al. (2018) Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease. Alzheimers Res Ther 10:80
Bi, Rui; Kong, Li-Li; Xu, Min et al. (2018) The Arc Gene Confers Genetic Susceptibility to Alzheimer's Disease in Han Chinese. Mol Neurobiol 55:1217-1226

Showing the most recent 10 out of 1666 publications